Fulcrum Therapeutics
BiotechnologyCambridge, Massachusetts, United StatesPost-IPO Equity$778.3M total fundingwww.fulcrumtx.com
Latest funding:$175.0M · Post-IPO Equity (December 10, 2025)
Angel investors who backed Fulcrum Therapeutics
28 investors in our database backed Fulcrum Therapeutics.
Eli Casdin
Chief Investment Officer
Luke Bagaason, CFA
Manager - Portfolio Valuation
Dennis Ryan
Chief Financial Officer & Managing Director
Dorothy Margolskee
Managing Director
Richard Lau, CFA
Partner
Jeffrey Tong
Partner
Abbie Celniker
Partner
Neil Exter
Partner
Craig Muir
Partner and CTO
Cary Pfeffer
Partner
Mark Levin
partner
Walter Kowtoniuk
Venture Partner
Philip Reilly
venture partner
Josephine Kahn
Senior Associate / Consultant
George Xu
Director, Corporate Strategy and Portfolio Development
Noreen Rizvi
Principal
Reid Huber
Partner
Christoph Lengauer
Adjunct Associate Professor
Andrew Warren
Senior Director, CSO Partner Team
Robert Tepper
Partner
William Motley
Senior Associate
Bill Maris
Founder
Steve Kafka
General Partner
Leon Chen
CEO and Founding Partner
Ching Zhu
Managing Partner
John Zhu
Venture Partner
Rebecca Zhu
Partner
Erdong Hua
Partner
Who invested in...
See every angel investor and VC behind well-known startups.
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Fulcrum Therapeutics.
Search investors